Mice harbouring a SCA28 patient mutation in AFG3L2 develop late-onset ataxia associated with enhanced mitochondrial proteotoxicity by Mancini, Cecilia et al.
This item was downloaded from IRIS Università di Bologna (https://cris.unibo.it/) 
When citing, please refer to the published version. 
 
 
This is the accepted manuscript  of:  
Mancini C, Hoxha E, Iommarini L, Brussino A, Richter U, Montarolo F, Cagnoli C, 
Parolisi R, Gondor Morosini DI, Nicolò V, Maltecca F, Muratori L, Ronchi G, Geuna S, 
Arnaboldi F, Donetti E, Giorgio E, Cavalieri S, Di Gregorio E, Pozzi E, Ferrero M, Riberi 
E, Casari G, Altruda F, Turco E, Gasparre G, Battersby BJ, Porcelli AM, Ferrero E, 
Brusco A, Tempia F. Mice harbouring a SCA28 patient mutation in AFG3L2 develop 
late-onset ataxia associated with enhanced mitochondrial proteotoxicity. Neurobiol 
Dis. 2019 Apr;124:14-28.  
Final peer reviewed version available at: https://doi.org/10.1016/j.nbd.2018.10.018 
Rights / License: 
The terms and conditions for the reuse of this version of the manuscript are specified in the 
publishing policy. For all terms of use and more information see the publisher's website.   
 
 - 1 - 
Mice harboring a SCA28 patient mutation in AFG3L2 develop late-onset ataxia 
associated with enhanced mitochondrial proteotoxicity  
 
Cecilia Mancini*1, Eriola Hoxha*2,3, Luisa Iommarini4, Alessandro Brussino1, Uwe Richter5, Francesca 
Montarolo2,3, Claudia Cagnoli1, Roberta Parolisi2,3, Diana Iulia Gondor Morosini2,3, Valentina Nicolò2,3, 
Francesca Maltecca6, Luisa Muratori3,7, Giulia Ronchi3,7, Stefano Geuna3,7, Francesca Arnaboldi8, Elena 
Donetti8, Elisa Giorgio1, Simona Cavalieri1, Eleonora Di Gregorio9, Elisa Pozzi1, Marta Ferrero1, Evelise 
Riberi10, Giorgio Casari6, Fiorella Altruda11, Emilia Turco11, Giuseppe Gasparre12, Brendan J. Battersby5, Anna 
Maria Porcelli4, Enza Ferrero1, Alfredo Brusco*1,9, Filippo Tempia*2,3. 
* These authors equally contributed to the work 
 
1 Department of Medical Sciences, University of Torino, Torino, Italy. 
2 Department of Neurosciences, University of Torino, Torino, Italy. 
3 Neuroscience Institute Cavalieri Ottolenghi (NICO), Orbassano, Italy. 
4 Department of Pharmacy and Biotechnologies (FABIT), University of Bologna, Bologna, Italy. 
5 Institute of Biotechnology, University of Helsinki, Helsinki, Finland. 
6 Università Vita-Salute San Raffaele and Division of Genetics and Cell Biology, San Raffaele Scientific 
Institute, Milan, Italy. 
7 Department of Clinical and Biological Sciences, University of Torino, Torino, Italy. 
8 Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy. 
9 Medical Genetics Unit, Città della Salute e della Scienza University Hospital, Torino, Italy. 
10 Department of Public Health and Pediatrics, University of Torino, Torino, Italy. 
11 Molecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, 
University of Torino, Torino, Italy. 
12 Department Medical and Surgical Sciences, Medical Genetics, University of Bologna, Bologna, Italy. 
 
Corresponding author: Alfredo Brusco, University of Torino, Department of Medical Sciences, via Santena 
19, 10126, Torino, Italy. E-mail: alfredo.brusco@unito.it 
 
 
Conflict of Interest: The authors have declared that no conflict of interest exists. 
 
 
 - 2 - 
ABSTRACT 
Spinocerebellar ataxia 28 is an autosomal dominant neurodegenerative disorder caused by missense 
mutations affecting the proteolytic domain of AFG3L2, a major component of the mitochondrial m-AAA 
protease. However, little is known of the underlying pathogenetic mechanisms or how to treat patients with 
SCA28. Currently available Afg3l2 mutant mice harbour deletions that lead to severe, early-onset neurological 
phenotypes that do not faithfully reproduce the late-onset and slowly progressing SCA28 phenotype. Here we 
describe production and detailed analysis of a new knock-in murine model harbouring an Afg3l2 allele carrying 
the p.Met665Arg patient-derived mutation. Heterozygous mutant mice developed normally but adult mice 
showed signs of cerebellar ataxia detectable by beam test. Although cerebellar pathology was negative, 
electrophysiological analysis showed a trend towards increased spontaneous firing in Purkinje cells from 
heterozygous mutants with respect to wild-type controls. As homozygous mutants died perinatally with 
evidence of cardiac atrophy, for each genotype we generated mouse embryonic fibroblasts (MEFs) to 
investigate mitochondrial function. MEFs from mutant mice showed altered mitochondrial bioenergetics, with 
decreased basal oxygen consumption rate, ATP synthesis and mitochondrial membrane potential. 
Mitochondrial network formation and morphology was altered, with greatly reduced expression of fusogenic 
Opa1 isoforms. Mitochondrial alterations were also detected in cerebella of 18-month-old heterozygous 
mutants and may be a hallmark of disease. Pharmacological inhibition of de novo mitochondrial protein 
translation with chloramphenicol caused reversal of mitochondrial morphology in homozygous mutant MEFs, 
supporting the relevance of mitochondrial proteotoxicity for SCA28 pathogenesis and therapy development.  
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INTRODUCTION 
The hereditary spinocerebellar ataxias (SCAs) are a group of over 40 neurodegenerative disorders 
characterized by autosomal dominant inheritance (Ashizawa et al., 2018). Although each form of SCA has its 
own distinct causative gene, the pathogenetic pathways converge on cerebellar and spinal degeneration leading 
to an array of slowly progressive neurological deficits (Ashizawa et al., 2018; Nibbeling et al., 2017; Smeets 
and Verbeek, 2014). We first described SCA type 28 (SCA28) over a decade ago in a four-generation Italian 
family with ataxia (Cagnoli et al., 2006; Di Bella et al., 2010; Mariotti et al., 2008), and later identified 
mutations in AFG3L2 (AFG3 ATPase Family Member 3-Like 2) as the cause of disease (Di Bella et al., 2010). 
Clinically, the age of onset ranges widely (from 3 to 76 years) and mean age of onset is 19.5 years. The 
principal manifestations are altered balance and gait, but limb ataxia, dysarthria and eye movement 
abnormalities have also been observed. The disease course is very slow, and patients remain ambulant into 
their late sixties. The principal finding by brain MRI is cerebellar atrophy, that usually appears as first hallmark 
of the disease (Brussino et al., 2018).  
SCA28 is a rare disease, representing ~1.5% of all autosomal dominant cerebellar ataxias (whose 
prevalence is 1-9/100,000). SCA28 has no treatment options, also because we lack a mechanistic understanding 
of disease pathogenesis. SCA28 is unique in being currently the only form of dominant ataxia caused by 
dysfunction of a mitochondrial-dwelling protein (http://neuromuscular.wustl.edu/ataxia/domatax.html). The 
causative gene AFG3L2 is part of the nuclear genome and encodes a protein subunit that forms the m-AAA 
protease (matrix-ATPase associated with diverse cellular activities), a multimeric complex bound to the inner 
mitochondrial membrane (Koppen et al., 2007). The m-AAA protease is part of a complex network of 
evolutionarily conserved proteases that represent the most important inner defence system of mitochondrial 
integrity (Koppen and Langer, 2007; Patron et al., 2018), which is maintained also by other mechanisms such 
as regeneration or culling of compromised mitochondria by mitochondrial dynamics (fusion and fission) and 
removal of damaged organelles by mitophagy (Liesa et al., 2009). The m-AAA protease is a crucial component 
of the mitochondrial protein quality control system, exerting a chaperone-like activity during biogenesis of 
oxidative phosphorylation (OXPHOS) respiratory chain complexes. The m-AAA also participates in 
mitochondrial protein processing and maturation (Arlt et al., 1998; Atorino et al., 2003; Gerdes et al., 2012; 
Koppen and Langer, 2007; Nolden et al., 2005). 
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In humans, AFG3L2 is a major constituent of the m-AAA protease, being capable of self-aggregation 
to form the homo-hexameric form of m-AAA. AFG3L2 can also form hetero-hexamers in partnership with its 
paralogue SPG7 (alias paraplegin) (Koppen et al., 2007). To become active, both AFG3L2 and SPG7 
themselves need to be proteolytically processed. However, while AFG3L2 is capable of self-activation, SPG7 
requires AFG3L2 for maturation and activation via tyrosine phosphorylation, and does not self-assemble 
(Almontashiri et al., 2014; Koppen et al., 2009). Mutations in SPG7 are associated with the genetic disorder 
hereditary spastic paraplegia type 7 (Casari et al., 1998).  
Structurally, the m-AAA protease is essentially an ATP-fueled proteolytic machine shaped like a 
double-doughnut: the juxtamembrane doughnut represents the ATPase domain while the proteolytic domain 
protrudes into the mitochondrial matrix (Koppen & Langer 2007). Functionally, using as model the bacterial 
homologue FtsH, we can imagine substrates being pulled through the hexamer ring of the AAA domain into 
the proteolytic cleft of the protease ring, with release of degradation peptides (Dalbey et al., 2012).  Recently, 
Ding et al. demonstrated that a precursor form of the human MrpL32 (a mitoribosomal protein required for 
ribosomal assembly and protein synthesis) is targeted to AFG3L2, suggesting that m-AAA substrates may be 
evolutionary conserved (Almajan et al., 2012; Ding et al., 2018; Nolden et al., 2005). 
We dwell on the complexities of the m-AAA structure, function and composition because it emerges 
that the majority of SCA28 patient mutations induce missense changes in AFG3L2 residues that participate in 
the formation of the proteolytic cleft. These missense mutations are mostly clustered in AFG3L2 exons 15 and 
16 that form the protease domain: 654Thr→Ile; 666Met→Val/Arg/Thr; 671Gly→Arg/Glu; 674Ser→Leu; 
689Tyr→Asn/His; 691Glu→Lys; 694Ala→Glu; 700Glu→Lys and 702Arg→Gln (Almajan et al., 2012; Cagnoli et 
al., 2010; Di Bella et al., 2010; Edener et al., 2010; Lobbe et al., 2014; Szpisjak et al., 2017; Zuhlke et al., 
2015). Confirmation of the importance of modifications in the proteolytic cleft for disease pathogenesis comes 
from the 432Asn→Thr patient mutation: although encoded by exon 10, thus outside of the mutational hotspot, 
it modifies a cleft-facing residue from the ATPase aspect. Two pathogenic frameshift mutations have also been 
described in SCA28: deletion of exons 14-16 and the p.Thr654Asnfs*15, again affecting the protease domain 
(Musova et al., 2014; Smets et al., 2014).  
In addition to these observations on the nature and location of the patients’ mutations, we note that the 
Exome Aggregation Consortium (ExAC) database (Lek et al., 2016) describes many human AFG3L2 variants 
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(synonymous, missense, frameshift, gain of stop codon and altered splice sites) that are distributed throughout 
all the coding region. However, the loss-of-function AFG3L2 variants, whose frequency in the human 
population analysed is ~1:2000 (i.e., far higher than the incidence of SCA28) are not deleterious, and ExAC 
gives a probability of LoF intolerance (pLI) of 0.01, indicating that AFG3L2 is extremely tolerant to loss-of-
function changes, although it must be remembered that due to the late-onset of the phenotype, it is possible 
that some of the mutations have not had time to become manifest. It is evident that what is not tolerated is a 
select group of heterozygous missense mutations that do not appear to affect AFG3L2 protein levels but instead 
lead to incorporation of malfunctioning AFG3L2 subunits into the m-AAA complexes, which in turn become 
dysfunctional. AFG3L2 is highly expressed in cerebellum and other neural tissues, and our working hypothesis 
for SCA28 pathogenesis is that mitochondrial dysfunction in these tissues leads to proteotoxic stress through 
the slow accumulation of toxic misfolded substrates, a process already described in other neurodegenerative 
diseases such as Alzheimer’s and Parkinson’s diseases (Sorrentino et al., 2017). The ensuing 
mitochondriopathy eventually translates into neurodegeneration and neurological manifestations.  
A mouse model of SCA28 would be an ideal approach to test our mitotoxicity hypothesis. Two murine 
mutations affecting Afg3l2 have already been described: one is the paralysé mouse (Afg3l2par/par), carrying the 
spontaneous Arg389Gly mutation in the conserved AAA domain, and the second is the Afg3l2Emv66/Emv66 mouse, 
in which Afg3l2 protein is absent because of a murine leukemia proviral insertion in intron 14 (Maltecca et 
al., 2008). Both mutants are smaller than normal littermates at one week, show a progressive loss of limb motor 
function by two weeks, and are completely paralyzed and usually die by 3 weeks. Mice present severe defects 
in neuronal development, with axonal development failure, aberrant mitochondria, Schwann cell invagination, 
and impaired maturation of Purkinje cell arborization (Maltecca et al., 2008). Compound heterozygotes 
(Afg3l2par/Emv66) are phenotypically indistinguishable from their respective homozygotes, suggesting that both 
mutations act by loss of a protective function (Maltecca et al., 2008). The models have proven valuable in 
deciphering the functional role of Afg3l2 in axonal development, where it is required for correct assembly of 
respiratory chain complexes (Maltecca et al., 2008). In contrast, heterozygous Afg3l2 Emv66/+ mice have a milder 
phenotype, with the first signs of loss of balance appearing at four months and worsening with age, suggesting 
a dose-effect of the mutation (Maltecca et al., 2009). Additional informative models are the Spg7-/- Afg3l2Emv66/+ 
digenic mutated mice obtained by crossing the Afg3l2Emv66/+ strain with SPG7 knock-out mice (Martinelli et 
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al., 2009) . These mice have a severe phenotype, characterized by early-onset loss of balance, tremor, and 
ataxia with altered gait coordination. Lastly, there is the Afg3l2PC-KO mouse, which limits Afg3l2 inactivation 
to Purkinje cells. Again, the phenotype is severe with unsteady gait at six weeks, caused by dramatic loss of 
Purkinje cells (Almajan et al., 2012). All these models serve to highlight the crucial role of Afg3l2 in 
maintaining normal cerebellar function, and that loss of Afg3l2 leads to disease with severe ataxic phenotypes. 
However, these models do not resolve the question of how the AFG3L2 missense mutations affecting the 
protease domain lead to SCA28. 
With these considerations in mind, we hoped to generate a more authentic mouse model of disease by 
taking advantage of the fact that human and murine AFG3L2 proteins are highly conserved. This paved the 
way for knock-in generation by modifying one Afg3l2 allele through insertion of a SCA28 patient mutation. A 
potential drawback of this model is that rodent genomes harbour Afg3l1, a paralogue of Afg3l2 and Spg7 that 
is pseudogenized in human (Kremmidiotis et al., 2001). However, Afg3l1 shows very low expression in brain 
and cerebellum (Sacco et al., 2010) and does not rescue the phenotype of either Afg3l2 or Spg7 knock-out mice 
(Wang et al., 2016). Thus, we proceeded with our model, selecting the AFG3L2 missense mutation 
c.1994T>G:p.Met666Arg (p.Met665Arg in mouse), reported in a familial case of SCA28 (Cagnoli et al., 
2010). Here we describe: (i) the generation and motor behavior of the Afg3l2M665R knock-in mouse; (ii) a 
detailed investigation of the effects of the mutation on neural tissues and their ultrastructure; (iii) a validation 
of the mitochondrial proteotoxicity model and (iv) that the antibiotic chloramphenicol can revert the mitotoxic 
phenotype, opening a potential new avenue of treatment.      
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MATERIALS AND METHODS 
Generation of Afg3l2M665R/+ knock-in mice  
To generate our knock-in mouse model, we used a gene targeting approach to introduce the M665R 
mutation into Afg3l2. The targeting vector was constructed using the recombineering strategy 
(www.recombineering.ncifcrf.gov) (Copeland et al., 2001) and consisted of a 14.1 kb NotI-XhoI fragment from 
the BAC bmp360E12 (mouse strain 129) containing exon 16 and the flanking intron sequences (5,261 bp 
upstream and 7,128 bp downstream) of murine Afg3l2. In a second vector, we cloned a 0.6 kb region flanking 
exon 16 into which we introduced, through SalI-NotI restriction cloning, the neor cassette flanked by two 
Flippase recognition target sequences. The c.1994T>G point mutation (p.Met665Arg) was introduced by site-
directed mutagenesis (Stratagene) together with an NcoI restriction site at the 5’ end of exon 16 to allow 
discrimination between wild-type and mutated alleles by Southern blot. We used recombineering to generate 
the final vector for electroporation into mouse 129 ES cells. After positive selection with neomycin, 230 clones 
were harvested; 10 were positive by Southern blot using NcoI/SmiI-digested DNA. The Southern blot probe 
was a ∼300-bp fragment of Afg3l2 cloned into pUC19 after PCR amplification of mouse genomic DNA 
(primers 5’-ttcaggtctttcactggcatggt; 5’-gcaacacagtactatacacctccttacg). The probed yields a 17.1 kb band in 
wild-type DNA, and 13.4 kb in mutant cells. The neor cassette copy number was evaluated by real-time PCR 
(Mancini et al., 2011). Only 2/10 ES cell lines showed a single neor insertion and were injected into C57BL/6 
blastocysts. The resulting chimeras were then mated to C57BL/6 females to obtain germline transmission. A 
diagnostic restriction enzyme digest was set up to verify the heterozygous presence of the mutation in mice: 
exon 16 was amplified using primers mAfg3l2_16F (5’-gctggtgcggtttgcccag) and mAfg3l2_16R (5’-
cagcaggtagacactagctaagcaacc). Amplicons were digested with Hsp92II that cuts only the wild-type allele. The 
genotype of mice was confirmed by PCR, followed by Sanger sequencing. The neor cassette was eliminated 
by crossing Afg3l2M665R-neo/+ mice with a mouse strain containing the Flippase recombination enzyme. 
Afg3l2M665R/+ animals were backcrossed with C57BL/6J for at least seven generations to purify the genetic 
background. Studies were performed in accordance with the guidelines of the Neuroscience Institute Cavalieri 
Ottolenghi (NICO) (Orbassano, Italy), after obtaining approval by the Ethics Committee of the University of 
Torino, and following authorization from the Italian Ministry of Health (Authorization no.: 58/2016-PR). 
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Assessment of motor phenotype 
Motor tests were performed every two months to detect the onset of neurological signs, starting when 
mice were 4 months old. The methods were as follows for 18 month old mice. The 18-month-old wild-type 
and Afg3l2M665R/+ littermates were of similar weight (wild-type: 25.38 ± 1.11 g, n = 11; Afg3l2M665R/+: 25.98 ± 
0.62 g, n =18; P > 0.05). For the beam test (Goldowitz, 1992), Afg3l2M665R/+ mice (n = 16) and their control 
littermates (n = 14) were placed on a metal beam (80 cm long x 1 cm wide) suspended above an open cage. 
Mice were allowed to traverse the beam for four days before the test (habituation). During the test, lateral slips 
were counted in three complete and consecutive crossings per day, on two consecutive days. The mean number 
of slips per 80 cm travelled was calculated. Footprint analysis was carried out using wild-type (n = 8) and 
Afg3l2M665R/+(n = 8) mice, as described in Hoxha et al. (Hoxha et al., 2013). Briefly, a cardboard tunnel was 
constructed on a transparent plexiglass platform (4 cm wide x 40 cm long). Video footage of mouse walks was 
obtained and analyzed using ImageJ software. In the accelerating rotarod test, wild-type (n=13) and 
Afg3l2M665R/+(n=13) mice were tested on five consecutive days, and on day 10. Each day, after 1 min training 
at constant speed (4 rpm), mice had three test sessions in which the rod (Mouse Rota-Rod, Ugo Basile 
Biological Research Apparatus, Comerio, Italy) accelerated continuously from 4 to 65 rpm over 300 s. The 
time to falling off the rod was recorded. 
The optokinetic reflex (OKR) was measured to assess visual function. The OKR was evoked using a 
rotating optokinetic drum with an 8° vertical grating. After placing the mouse on a central platform in the 
drum, and allowing 1 min for acclimation, the drum was rotated counterclockwise for 1 min, stopped for 10 s 
and then rotated clockwise for another minute. Rotation velocity was 10°/s. The mouse was video-recorded 
and visual head tracking was measured offline (Thaung et al., 2002). Since the animal was free, there were 
episodes in which it spontaneously explored the environment, while in the remaining time the animal was still. 
Only the still-time was analysed (about 30 seconds). The degree of optokinetic response was calculated as the 
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Eighteen-month-old Afg3l2M665R/+ (n = 3) and wild-type (n = 3) mice were anaesthetised by 
intraperitoneal injection with ketamine (100 mg/kg body weight) and xylazine (10 mg/kg body weight), and 
perfusion-fixed with 4% paraformaldehyde in 0.12M phosphate buffer (PB). Brains were removed and 
immersed in the same fixative at 4°C for 18h and then cryoprotected in 30% sucrose in 0.12M PB. Cerebella 
were frozen and serially cut on a freezing microtome into 30 μm-thick sagittal sections. To label Purkinje cells, 
one set of sections was incubated overnight at 4°C with anti-calbindin-D28k polyclonal antibody (CB-38a, 
1:3000; Swant, Bellinzona, CH) diluted in PBS with 0.25% Triton X-100 and 1.5% normal goat serum. 
Immunohistochemical reactions were stained with avidin-biotin-peroxidase (Vectastain ABC Elite kit; Vector 
Laboratories, Burlingame, CA, USA) and revealed using 3,3′-diaminobenzidine (0.03% in Tris–HCl) as 
chromogen. A second set of sections was Nissl-stained to gauge the thickness of the molecular and granule 
cell cerebellar layers, and to quantify neuronal density (cell number/mm2) in the deep cerebellar nuclei (DCN). 
Morphometric analysis of the cerebellar sections was performed by means of the Neurolucida system 
(MicroBrightField, Williston, VT, USA) and ImageJ software (http://rsbweb.nih.gov/ij/index.html). 
 
Purkinje cell firing 
Cerebellar slices were prepared as previously described (Llinas and Sugimori, 1980 and Edwards et 
al., 1989). Mice were anaesthetized with isoflurane (Isoflurane-Vet, Merial, Italy) and decapitated. The 
cerebellar vermis was removed and transferred to ice-cold artificial cerebrospinal fluid (ACSF) containing (in 
mM); 125 NaCl, 2.5 KCl, 2 CaCl2, 1 MgCl2, 1.25 NaH2PO4, 26 NaHCO3, 20 glucose, bubbled with 95% O2/5% 
CO2 (pH 7.4). Parasagittal cerebellar slices (200 μm thickness) were obtained using a vibratome (Leica 
Microsystems GmbH, Wetzlar, Germany) and kept for 1 h at 35°C and then at 31°C. Single slices were placed 
in the recording chamber, which was perfused at a rate of 2–3 ml/min with ACSF bubbled with the 95% O2/5% 
CO2. All recordings were performed at 31±1°C temperature. For cell-attached recording, the pipette was filled 
with 0.9 % NaCl, 0.2 μm filtered. Recordings were made using an EPC‐10 patch‐clamp amplifier (HEKA 
Elektronik, Lambrecht/Pfalz, Germany). Gabazine (SR 95531, 20 μM), DAP5 (50 μM) and NBQX (10 μM) 
were added to the perfusate to inhibit the GABAA and ionotropic glutamate receptors of Purkinje cells, 
respectively. Data was derived from the analysis of 3 - 5 animals. All drugs were purchased from Abcam. 
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Electron microscopy 
Sciatic nerve. To prepare sciatic nerve sections, 18-month-old wild-type mice (n= 5) and 
Afg3l2M665R/+(n= 5) were anaesthetised by intraperitoneal injection with ketamine (100 mg/kg body weight) 
and xylazine (10 mg/kg body weight). Using an operative microscope, the sciatic nerve was carefully exposed 
and removed. Nerves were immediately fixed by immersion in 2.5% glutaraldehyde in 0.1 M phosphate buffer 
(pH 7.4) for 4 - 6 h at 4°C. Samples were postfixed in 2% osmium tetroxide for 2 h and dehydrated in ethanol 
from 30% to 100%. After two passages of 7 min each in propylene oxide and overnight in a 1: 1 mixture of 
propylene oxide and Glauerts’ mixture of resins, sciatic nerves were embedded in equal parts of Araldite M 
and the Araldite Harter resin, with further addition of 0.5% dibutylphthalate plasticizer. Finally, 2% of 
accelerator 964 was added to the resin in order to promote the polymerization of the embedding mixture.  
Light microscopy and design-based quantitative morphology of sciatic nerves. From each nerve, 2.5-
μm-thick series of semi-thin transverse sections were cut using an Ultracut UCT ultramicrotome (Leica 
Microsystems, Wetzlar, Germany) and stained with 1% Toluidine blue for high resolution light microscopic 
examination and design-based stereology. A DM4000B microscope equipped using a DFC320 digital camera 
and an IM50 image manager system (Leica Microsystems) was used for stereology of nerve fibers. On one 
randomly selected toluidine blue stained semi-thin section, the total cross-sectional area of the whole nerve 
was measured by light microscope and 12 - 16 sampling fields were selected by systematic random sampling 
(Geuna, 2000; Geuna et al., 2000; Larsen, 1998). In each sampling field, a two-dimensional dissector 
procedure, which is based on sampling the “tops” of fibers, was adopted in order to avoid the “edge effect” 
(Geuna, 2000). Using this procedure, the total number of myelinated fibers (N) was estimated. In addition, 
both fiber and axon areas were measured, and the diameter of fiber (D) and axon (d) were calculated. These 
data were used to calculate myelin thickness [(D−d)/2], myelin thickness/axon diameter ratio [(D−d)/2d], and 
axon/fiber diameter. 
Quantitative analysis of mitochondria in sciatic nerves. Ultra-thin (70 nm) sections were cut from the 
sciatic nerves using the same ultramicrotome described for the high resolution light microscopy (above). Nerve 
sections were stained with saturated aqueous solution of uranyl acetate and lead citrate. Ultra-thin sections 
were analyzed using a JEM-1010 transmission electron microscope (JEOL, Tokyo, Japan) equipped with a 
Mega-View-III digital camera and a Soft-Imaging-System (SIS, Münster, Germany) for computerized 
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acquisition of the images. On one randomly selected ultra-thin section, 10 - 15 fields were selected using a 
systematic random sampling protocol, with a magnification of ×15000. In each sampling field, the number of 
impaired and unimpaired mitochondria was estimated as %, based on their morphological features such as the 
shape of mitochondria, the morphology of the cristae and evidence of swelling. 
Cerebellar and lumbar spinal cord electron microscopy. After excision of sciatic nerves, animals were 
perfused-fixed with 3% glutaraldehyde diluted in 0.1 M Sorensen phosphate buffer (pH 7.4) to prepare 
cerebellar and lumbar spinal cord sections. Bioptic fragments obtained by cerebellum and lumbar spinal cord 
were immersed in 3% glutaraldehyde diluted in 0.1 M Sorensen phosphate buffer for 4 hours at 4°C, washed 
x3 for 30 min in Sorensen phosphate buffer, and post-fixed in 1% Osmium Tetroxide. After dehydration 
through an ascending series of ethanol solutions, samples were embedded in Durcupan (Durcupan, Fluka, 
Milan, Italy). Ultra-thin sections were obtained with an Ultracut ultramicrotome (Reichert Ultracut R-
Ultramicrotome, Leika, Wien, Austria) and stained with uranyl acetate/lead citrate before observation by a Jeol 
CX100 transmission electron microscope (Jeol, Tokyo, Japan). 
 
Caudal nerve conduction velocity.  
To measure caudal nerve conduction velocity (NCV), mice were anaesthetised via intraperitoneal 
injection with ketamine (100 mg/kg body weight) and xylazine (10 mg/kg body weight). Stainless steel 
subdermal needle electrodes were used to deliver supramaximal stimulation with 0.05 millisecond impulses 
using an isolated stimulator (A-M System 2100, Sequim, WA, USA). Low frequency filters were set to 300 
Hz and high frequency filters were set to 10 kHz. NCV in the tail nerve was assessed by placing needle 
electrodes in the tail, with the positive recording electrode at a few cm from the base of the tail. In proximal to 
distal direction, the distances from the first electrode were: negative recording electrode 0.5 cm, ground 1.5, 
negative stimulation electrode 4 cm, positive stimulation electrode 4.5 cm. The latencies of the potentials 
recorded after nerve stimulation were determined and the NCV was calculated accordingly. All 
neurophysiological determinations were performed under standard conditions and external body temperature 
was maintained at 34°C with a heating lamp. 
 
Mouse embryonic fibroblasts (MEF) production and analysis 
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Generation of MEFs. Primary MEFs were established from embryos obtained on day E13.5 from wild-
type, KI-hz Afg3l2M665R/+ and KI-ho Afg3l2M665R/M665R mice using a standard protocol (Sharpless, 2006) with 
immortalization by SV40 plasmid transfection followed by 300 µg/ml G418 antibiotic selection (Schuermann, 
1990). 
Analysis of mitochondrial morphology. Mitochondrial network morphology was analysed using the 
mito-RED probe (Invitrogen) and live imaging confocal microscopy. An average of 150 cells was analyzed 
for each experimental condition. Mitochondrial length was measured using ImageJ software tools. 
Experiments were repeated at least three times, and two operators independently analysed the images. The t-
student test on raw data was to calculate significance (p < 0.05). 
Western blot analysis. Total cell or tissue lysates were prepared by protein extraction in RIPA buffer. 
Twenty µg of proteins were separated by electrophoresis on 4-12% Bis-Tris Protein Gels (Life Technologies). 
Anti-Afg3l2 (14631-1AP, polyclonal rabbit) and anti-Oma1 (17116-1AP, polyclonal rabbit, specific for pre-
pro-Oma1 of 60 kDa) antibodies were purchased from Proteintech. Anti-Vinculin (Millipore, #AB6039) or 
anti-β-actin (Lifespan, LS-C51570) were used as loading controls. For Opa1 band processing, we performed 
standard western blotting with total cell or tissue lysates prepared by protein extraction using a Triton-
containing buffer (Maltecca et al., 2012). Twenty µg (MEFs) and 5 µg (tissues) were separated by 
electrophoresis on 8% Bolt™ Bis-Tris Plus Gels (Life Technologies). Anti-Opa1 antibody was purchased from 
BD Transduction Laboratories #612606 (Franklin Lakes, NJ, USA). Anti-Viculin was used as loading control. 
 
Analysis of mitochondrial bioenergetics 
Preparation of crude mitochondria. Dissected tissues were promptly chopped and homogenized (30 
strokes) in 10 volumes/g wet tissue of mannitol/sucrose buffer (220 mM D-mannitol, 70 mM sucrose, 20 mM 
HEPES, 1 mM EDTA and 0.1% BSA, pH 7.2) in a glass-Teflon pestle. The crude homogenate was centrifuged 
at 500 g for 10 min at 4°C. The low-speed supernatant was centrifuged at 10,000 g for 10 min at 4°C. The 
resulting mitochondrial pellet was carefully re-suspended to about 10–20 mg/ml in mannitol/sucrose buffer. 
Protein concentration was determined by Bradford’s method (BioRad, Hercules, CA, USA) with BSA as the 
standard. 
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Respiratory complex activity. Mitochondrial respiratory chain complex activity was assayed and 
normalized for protein content and citrate synthase (CS) activity as previously described (Ghelli et al., 2013). 
All drugs used for biochemical analyses were from Sigma-Aldrich (St Louis, MO, USA). 
Native gel electrophoresis. To analyze isolated native complexes, mitoplasts were suspended in a 
buffer containing 750mM aminocaproic acid, 50 mM Bis-Tris, pH 7.0, and solubilized with 20% n-Dodecyl 
beta-D-maltoside (DDM), corresponding to a DDM/protein ratio of 2.5 (g/g). The suspension was incubated 
on ice for 10 min and then centrifuged at 13,000 g for 15 min (Ghelli et al., 2013). Solubilized mitochondrial 
proteins (80 µg) were separated on native 4 - 16% Bis-Tris Gel (Invitrogen), as detailed before (Ghelli et al., 
2013). Gels were run as high resolution Clear Native- and Blue Native-PAGE (hrCN- and BN-PAGE). After 
electrophoresis, samples in CN-PAGE gels were processed for CI in-gel-activity (CI-IGA); samples in BN-
PAGE gels were used for western blotting. Immunodetection was carried out by incubating blots with 
antibodies directed against the NDUFA9 subunit of CI (Thermo Fisher Scientific), SDHA subunit of CII 
(Thermo Fisher Scientific), UQCRC2 subunit of CIII (AbCAm, Cambridge, UK), and COXIV of CIV 
(AbCam, Cambridge, UK).  
Mitochondrial Respiration assay. Oxygen consumption rate (OCR) in adherent cells was measured 
with by XFe24 Extracellular Flux Analyzer (Seahorse Bioscience, Billerica MA, USA), as previously 
described (Iommarini et al., 2014). Briefly, cells were seeded in XFe24 cell culture microplates at 2×104 
cells/well in 200 μl complete medium and incubated at 37°C in 5% CO2 for 24 h. Assays were initiated by 
replacing the growth medium in each well with 670 μl of unbuffered DMEM-high glucose supplemented with 
1 mM Na-pyruvate pre-warmed at 37°C. Cells were incubated at 37°C for 30 min to allow temperature and 
pH to equilibrate. After obtaining the OCR baseline measurement, 1μg/ml oligomycin, 0.25 μM FCCP ((2- [2-
[4-(trifluoromethoxy)phenyl]hydrazinylidene]-propanedinitrile), 1μM rotenone and 1μM antimycin A were 
sequentially injected. At the end of each experiment, the medium was removed and protein content was 
determined by sulforhodamine B (SRB) assay. OCR data (pmol/min) were normalized to SRB absorbance 
(Iommarini et al., 2014). First, the basal oxygen consumption rate (basal respiration) was measured. 
Oligomycin inhibited ATP synthase activity, which led to the development of a proton gradient that inhibited 
electron flux and revealed the state of the coupling efficiency. FCCP uncoupled the respiratory chain and 
revealed the maximal capacity for reducing oxygen. The spare respiratory capacity was calculated by 
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subtracting the basal respiration from the maximal respiration. Finally, rotenone combined with antimycin A 
was injected to inhibit the flux of electrons through complexes I and III; the remaining oxygen consumption 
rate was primarily due to non-mitochondrial respiration.  
 
Mitochondrial ATP synthesis assay 
The rate of mitochondrial ATP synthesis was measured in digitonin-permeabilized cells as previously 
described (Ghelli et al., 2013). Briefly, after trypsinization, cells (10×106/ml) were suspended in buffer (150 
mM KCl, 25 mM Tris–HCl, 2 mM EDTA, 0.1% BSA, 10 mM potassium phosphate, 0.1 mM MgCl2, pH 7.4), 
maintained at room temperature for 15 min, then incubated with 50 μg/ml digitonin until 90-100% of cells 
were positive by Trypan blue staining. Aliquots (3×105) of permeabilized cells were incubated in the same 
buffer as above in the presence of the adenylate kinase inhibitor P1,P5-di(adenosine-5′) pentaphosphate (0.1 
mM) and CI substrates (1 mM malate plus 1 mM pyruvate), CII substrate (5 mM succinate plus 1 μM rotenone) 
or CIII substrate (50 µM DBH2 plus 1 μM rotenone and 5 mM malonate). After the addition of 0.2 mM ADP, 
chemiluminescence was determined as a function of time with a luminometer (Sirius-L, Berthold, Germany). 
The chemiluminescence signal was calibrated with an internal ATP standard after the addition of 1 μM 
oligomycin. The rate of ATP synthesis was normalized to protein content and CS activity. 
 
Mitochondrial Δψm assay  
Mitochondrial Δψm was assessed by FACS analysis, after incubating cells with 20nM tetra-
methylrhodamine methyl ester perchlorate (TMRM) (Molecular Probes) for 30 min at 37°C. After this, 
mitochondria were fully depolarized by addition of 5 µM CCCP, as internal control. Data were analysed by 
WinList software (Verity Software House). 
 
Mitochondrial in vitro translation 
Mitochondrial protein synthesis was analysed in cultured cells by metabolic labelling with 
[35S]methionine/cysteine in the presence of anisomycin to inhibit cytoplasmic ribosomes, as described in 
(Richter et al., 2015).  
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RESULTS  
Generation of Afg3l2M665R/+ knock-in mice 
A targeting vector for insertion of the c.1994T>G (p.Met665Arg) missense mutation in Afg3l2 was 
prepared by recombineering (Copeland et al., 2001) (Fig. 1A). Briefly, the construct contained homologous 
DNA arms (C57BL/6J mouse strain), a neor cassette and a diagnostic NcoI restriction site for Southern blotting. 
Following vector transfection into 129 embryonic stem (ES) cells, clones with one mutated allele and a single 
copy of neor were identified (Fig. 1B-C), and transferred to C57BL/6 blastocysts for germline transmission. 
Afg3l2M665R/+ knock-in (KI) mice were born at the expected Mendelian ratios, and were normal in terms of 
appearance, development and fertility. Expression of both KI and wild-type (WT) alleles was verified by RT-
PCR and western blotting in different tissues, including cerebellum (Fig. 1D-F) and brain (data not shown).  
When heterozygous mutant mice were intercrossed, the expected Mendelian ratio at birth was skewed 
towards heterozygous and wild-type genotypes (Afg3l2+/+ 39/121, Afg3l2M665R/+ 75/121, Afg3l2M665R/M665R 
7/121; Chi-square test, p = 0.0003). Most homozygous mutant mice died before or within hours of birth; rare 
viable mice were cyanotic. We obtained embryonic day 16.5 (E16.5) embryos for histological analyses (Supp. 
Fig. S1A); in Afg3l2M665R/M665R embryos, the principal finding was diffuse cardiac atrophy while cerebellar 
histology appeared normal, although we cannot exclude a mild atrophy of the nervous system (Supp. Fig. S1B-
E). The cardiac phenotype and perinatal lethality of the Afg3l2M665R/M665R mouse contrasts with the 
Afg3l2Emv66/Emv66 mouse, which dies at around 2-3 weeks after birth with a neurological (tetraparetic) and 
cachectic phenotype (Maltecca et al., 2008), an indication that mutations that affect AFG3L2 quality 
(Afg3l2M665R/M665R) and quantity (Afg3l2Emv66/Emv66) have different phenotypic effects. We return to the main 
focus, our hypothetical SCA28 model mouse, and leave further investigations into the cardiac phenotype of 
the homozygous mutant to future studies.  
 
Late-onset motor incoordination in Afg3l2M665R/+ mice 
Although there was no outer evidence of disease, we started analysing motor behavior in Afg3l2M665R/+ 
mice and wild-type littermates at 4 months so as not to miss the onset of motor alterations. We took as a guide 
the fact that, at this age, Afg3l2 Emv66/+ mice show signs of motor incoordination. From the age of 4 months 
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onwards, motor testing was repeated every two months. The test battery included: (i) the elevated beam test; 
(ii) footprint analysis and (iii) the accelerating rotarod.  
When first examined (4 months), the tests showed no significant differences between wild-type and 
heterozygous mutants. However, at 18 months, Afg3l2M665R/+ mice started to show signs of imbalance on the 
beam test, with significantly greater number of fore paw and hind paw slips compared to wild-type littermates. 
Similar results were obtained when tests were repeated on consecutive days (Fig. 2A). In contrast, no 
differences were observed between groups of mice in footprint analysis (Fig. 2B), in the accelerating rotarod 
(Fig. 2C) nor in the day 10 rotarod test (Fig. 2C), which measured motor memory retention. Since optic atrophy 
has been associated with AFG3L2 mutations (Charif et al., 2015; Colavito et al., 2017), the optokinetic 
response to motion of the visual surroundings was assessed in Afg3l2M665R/+ and wild-type mice at 18 months. 
No significant difference in head tracking performance was observed between genotypes: tracking time with 
respect to total still-time was 81.4 ± 4.41% in wild-type mice, and 90.9 ± 2.10% in heterozygous mutants, 
ruling out vision loss. The test battery was repeated at 20, 22 and 24 months of age, with no evidence of 
increasing severity of the phenotype (data not shown). Thus, the heterozygous p.Met665Arg in Afg3l2 appears 
to be a mild mutation leading to adult-onset ataxia in mice that well recapitulates the SCA28 patient phenotype. 
 
Ataxic Afg3l2M665R/+ mice show normal cerebellar structure  
Cerebellar degeneration is central to ataxic neuropathology and usually precedes the onset of motor 
dysfunction. Therefore, we began examining cerebellar structure in heterozygous mutant mice from 6 months 
onwards, with no pathological finding. Even in 18-month-old ataxic heterozygotes, Nissl-stained cerebellar 
sections showed regular lamination and foliation as in control mice (Fig. 2D, E). Molecular and granular layer 
thickness was quantified in all cerebellar lobules, using a previously described method (Carulli et al., 2002), 
with no evident differences between genotypes (Fig. 2H, I).  
Since AFG3L2 is required for cerebellar Purkinje cell survival (Almajan et al., 2012),  Purkinje cell 
numbers were estimated by calbindin staining in cerebellar sagittal sections (Fig. 2F-G). The average number 
of Purkinje cells was similar in Afg3l2M665R/+ (46.2 ± 0.94 cells/mm; n = 3) and wild-type mice (43.2 ± 0.20 
cells/mm; n = 3) (Fig. 2J). Both groups also showed similar cell numbers in the deep cerebellar nuclei (data 
not shown).  
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Ataxic Afg3l2M665R/+ mice show normal spontaneous firing activity in Purkinje cells  
We next investigated Afg3l2M665R/+ Purkinje cell function by measuring the generation of spontaneous 
action potentials. Individual Purkinje cells in cerebellar slices were analysed by cell-attached patch clamp 
recordings. The mean interspike interval (ISI) was not significantly different in Purkinje cells from 18-month-
old wild-type and heterozygous mutant mice (Fig. 2K-L). The regularity of Purkinje cell firing was also 
conserved, as shown by the ISI coefficient of variation (Fig. 2M). The median of the interspike intervals was 
also similar for both genotypes (Fig. 2N). However, we did note an increase in the number of firing cells in 
Afg3l2M665R/+ mice, but this was not statistically significant - WT Purkinje cells: 47 analysed/21 silent/26 (55%) 
firing; Hz Purkinje cells: 36 analysed/9 silent/27 (75%) firing.  
 
Normal neural ultrastructure but alterations in sciatic nerve mitochondria in Afg3l2M665R/+ mice 
Previously described Afg3l2 mutant mouse models show altered mitochondrial morphology in cells of 
the nervous system (Maltecca et al., 2008; Maltecca et al., 2009). Therefore, we carried out detailed 
ultrastructural analyses of CNS- and PNS-derived tissues.   
Cerebellum. In 18-month-old wild-type and heterozygous mutant mice, the cerebellar cortex showed 
the typical molecular, Purkinje and granular layer organization, with clear boundaries between layers. Purkinje 
cells were aligned in monolayers, with cell bodies near the granular layer, a large nucleus within the piriformis-
shaped soma (Fig. 3A-B), and dendritic arborisations that crossed the molecular layer. No cell body shrinkage, 
enlargement of the ER cisternae nor fragmentation of the Golgi apparatus was observed. Mitochondria were 
normal with evident cristae and no signs of swelling (Fig. 3C-D). The granular layer was packed with small 
round cells (Fig. 3E-F).  
Spinal cord. Spinal cord white matter was similar in wild-type and Afg3l2M665R/+ mice: myelinated 
nerve fibers of small, medium and large diameter were ubiquitous, and myelinated sheaths showed uniform 
thickness (Fig. 3G-H). Axonal mitochondria always displayed conserved cristae, homogeneous matrix, and 
no signs of swelling (Fig. 3I-J). 
Sciatic nerve. Sciatic nerves were isolated and examined by high-resolution light microscopy. Nerve 
fibers showed similar organization and morphology, and similar size in axon diameter, fiber diameter and 
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myelin sheaths (Fig. 3K, L). Sciatic nerve fiber morphology by stereological analysis of myelinated fibers 
showed no significant differences between groups in the total number of myelinated fibers, axon diameter, 
fiber diameter and myelin thickness (Fig. 3M-P). Increased numbers of sciatic nerve mitochondria from 
Afg3l2M665R/+ mice showed altered cristae morphology and signs of swelling compared to wild-type, by 
stereological analysis: altered mitochondria in wild-type: 6.39 ± 1.97%; altered mitochondria in Afg3l2M665R/+: 
43.1 ± 4.98%.  (p <  0.0001, Chi-squared test) (Fig. 3Q, R). However, there were no discernible differences in 
peripheral nerve conduction of action potentials between groups: wild-type (n=7) 32.7 ± 1.2 m/s; Afg3l2M665R/+ 
(n=6) 32.9 ± 1.7 m/s.  
 
Mitochondrial bioenergetics are altered in Afg3l2M665R/+ mouse embryonic fibroblasts  
To analyse the impact of the p.Met665Arg mutation on mitochondrial function, we generated mouse 
embryonic fibroblasts (MEFs) from E13.5 embryos as these were available for the wild-type and mutant 
(Afg3l2M665R/+ and Afg3l2M665R/M665R) genotypes. MEFs were then used to analyse mitochondrial dynamics, 
bioenergetics, and oxidative phosphorylation (OXPHOS). Compared to wild-type MEFs, Afg3l2M665R/+ and 
Afg3l2M665R/M665R MEFs showed significant reduction in: (i) basal oxygen consumption rate; (ii) maximum 
respiratory capacity; (iii) spare respiration reserve and (iv) ATP-linked respiration, evaluated using the 
Seahorse system (Fig. 4A; Supp. Fig. S2A). In addition, Afg3l2M665R/+ MEFs showed reduced extracellular 
acidification rates, indicating reduced metabolic activity compared to controls (Fig. 4A; Supp. Fig. S2A). The 
mitochondrial membrane potential (ΔΨm) was significantly decreased in Afg3l2M665R/M665R MEFs (Fig. 4B) 
compared to wild-type at steady state, pointing to a defect in the proton pump possibly caused by impaired 
function of OXPHOS complexes.  
Reduced ATP-linked respiration was confirmed by ATP synthesis assay performed in digitonin-
permeabilized cells. Homozygous mutant MEFs exhibited a significant decrease of Complex I-driven and 
Complex II-driven ATP synthesis, indicating that the p.Met665Arg Afg3l2 variant impairs respiratory complex 
chain activity (Fig. 4C). By spectrophotometric analysis of isolated mitochondrial fractions, we found normal 
levels of activity in Complex I, II and IV in both Afg3l2M665R/+ and Afg3l2M665R/M665R MEFs. However, there was 
a 30% reduction of Complex III activity, which was statistically significant, in mitochondria isolated from 
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Afg3l2M665R/M665R MEFs. Citrate synthase activity was comparable in all three genotypes (Fig. 4D-E), indicating 
that there were no overall differences in mitochondrial mass.  
To evaluate mitochondrial protein maturation together with the assembly and stability of OXPHOS 
complexes, we analyzed mitochondrial in vitro translation, the steady-state levels of selected OXPHOS 
complex subunits and of fully assembled respiratory complexes by native PAGE. No differences were found 
between MEFs in terms of de novo mitochondrial protein synthesis assessed in organello after incorporation 
of 35S-Met/Cys (Supp. Fig. S2B), indicating proper synthesis of mitochondrial proteins in the presence of 
mutant Afg3l2. The steady-state levels of respiratory complex subunits in MEFs were similar for all genotypes 
(Supp. Fig. S2C). Fully assembled Complex III was reduced in Afg3l2M665R/M665R MEFs, possibly explaining 
the reduced Complex III redox activity found in these cells, whereas the other respiratory complexes were 
expressed in normal amounts (Supp. Fig. 2D).  
 
Altered mitochondrial dynamics induced by the p.Met665Arg mutation in MEFs and mutant mice 
To determine the impact of the p.M665R mutation on mitochondrial morphology, MEFs were treated 
with MitoRed to visualize fluorescently stained mitochondria. Afg3l2M665R/M665R MEFs showed fragmented 
mitochondria, reminiscent of observations made in both Afg3l2Emv66/Emv66 MEFs and mutant mice (Maltecca et 
al., 2012) whereas Afg3l2M665R/+ MEFs showed intermediate/tubular mitochondria (Fig. 5A, B).  
MEF expression of proteins that regulate mitochondrial fission and fusion were analysed by western 
blot. The GTPase Opa1 (Optic atrophy 1) is a major regulator of mitochondrial morphology: long isoforms 
(L-Opa1) promote mitofusion whereas the proteolytically-generated short forms (S-Opa1) instead trigger 
mitochondrial fragmentation and fission. Afg3l2M665R/M665R MEFs showed a remarkable decrease in L-Opa1, 
pointing to increased proteolytic processing to S-Opa1 (Fig. 5C). We also analysed expression of Drp1 (pro-
fission) and the mitofusins Mfn1 and Mfn2 in MEFS from the three genotypes, but found no major differences 
in expression (Supp. Fig. S2E).  
To return to our mouse model, we next evaluated Opa1 expression in neuronal tissues from wild type 
and heterozygous Afg3l2M665R/+ mice by western blot. L-Opa1 was greatly decreased in cerebella of 
Afg3l2M665R/+ mice (Fig. 5D) and in total brain lysate, but not in optic nerves. The S-Opa1/L-Opa1 ratio is 
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shown beneath each gel (Fig. 5D). Overall, these results suggest that mitochondrial fragmentation, specifically 
in cells of the brain and cerebellum, is altered in our mouse model of SCA28.  
 
Chloramphenicol treatment rescues the mitochondrial phenotype in Afg3l2M665R/M665R MEFs 
The increase in Opa1 processing with consequent fragmentation of the mitochondrial network, 
described above in our murine model, is proposed to be a primary event in our model of pathogenesis leading 
to SCA28. It has been reported that m-AAA malfunction triggers activation of OMA1, a back-up protease 
(ATP-independent) that cleaves OPA1 at the S1 cleavage site, leading to the formation of S1 and S3 isoforms 
(Anand et al., 2014; Ehses et al., 2009; MacVicar and Langer, 2016; Quiros et al., 2012). Accordingly, in our 
MEF model we found that both S1 and S3 forms of Opa1 were increased in homozygous mutant MEFs by 
western blotting (Fig. 5C). It is also known that OMA1 is synthesized as a pre-pro-protein of 60 kDa, which 
accumulates in parallel with the increase in cleaved OPA1 variants (Head et al., 2009).  Pre-pro-OMA1 
undergoes proteolytic processing after mitochondrial import, generating the stress-sensitive form, pro-OMA1 
(40 kDa). This in turn is cleaved to generate the active form of OMA1, which is responsible for OPA1 
processing (Baker et al., 2014). Very recently, AFG3L2 has been shown to play a major role in converting pre-
pro-OMA1 to pro-OMA1 (Consolato et al., 2018). A consequence of AFG3L2 malfunction is that 
mitochondrial protein synthesis leads to OMA-1 activation (Arlt et al., 1996; Richter et al., 2015). Similarly, 
we expected mitochondrial protein synthesis to perturb mitochondrial quality control in our mutant mouse 
model bearing dysfunctional m-AAA complexes containing Afg3l2 p.Met665Arg subunits. Prokaryotic and 
mitochondrial protein synthesis machineries are similar, so antibiotics such as chloramphenicol (CAM) that 
target bacterial ribosomes often affect mitochondrial protein synthesis too. We tried blocking mitochondrial 
protein synthesis in MEFs with CAM: remarkably, 24h CAM treatment completely restored L-Opa1 levels to 
normal in homozygous mutant MEFs (remaining elevated up to 24 h after treatment ended) and also rescued 
the fragmented mitochondrial phenotype (Fig. 6A-C). The results obtained with mice and MEFs bearing 
SCA28-type mutations are consistent with perturbed substrate recognition by Afg3l2, leading to mitochondrial 
proteotoxicity through gradual accumulation of incorrectly processed or improperly degraded proteins.   
 
DISCUSSION 
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Since the discovery of AFG3L2 as the causative gene of SCA28, understanding the molecular basis of 
this neurodegenerative disease has been a major goal. The route we selected here was to produce a genetically 
engineered mouse that mirrored the human disease as closely as possible. At the outset, the idea of modelling 
a mild human adult-onset ataxia in mice was not without risk, as their short life-span might not allow the time 
needed for the phenotype to develop.  
  A number of murine models targeting Afg3l2 have been developed, with genetic modifications not 
present in human SCA28. These models vary mechanistically from haploinsufficiency (Afg3l2Emv66/+) to 
complete deficiency in toto (Afg3l2Emv66/Emv66, Afg3l2par/par) to selective deficiency in Purkinje cells (Afg3l2PC-
KO). These models have been successful in creating severe disease phenotypes that recapitulate in part the 
neurological manifestations found in SCA28 (Almajan et al., 2012; Maltecca et al., 2008; Maltecca et al., 2009; 
Martinelli et al., 2009). However, none of the current models harbor a single-copy patient mutation. Thus the 
new knock-in mouse model reported here, in which one allele of Afg3l2 is modified to carry the 
c.1994T>G:p.Met666Arg point mutation (p.Met665Arg in mouse) derived from a SCA28 patient, can claim 
to genetically mirror the situation in humans. 
 How faithfully does the murine phenotype of the Afg3l2M665R/+ mouse recapitulate the human disease? 
In patients, the ataxic phenotype generally starts in adulthood and progresses very slowly (patients are usually 
not confined to a wheelchair until into their sixties or seventies). That our knock-in mice did develop a mild 
form of ataxia at 18 months of age is consistent with the human pattern of disease, just as the late-onset is 
consistent with the differences in human-mouse chronobiology. The mouse motor phenotype was detected by 
the beam walking test. This is the most sensitive method to reveal fine coordination defects and motor ataxia 
due to cerebellar dysfunction. However, the other motor tests were non-discriminatory. One possible 
interpretation is that although early cerebellar damage may be present, it does not yet affect most motor 
functions.  
How does the Afg3l2M665R/+ mouse compare to other mouse strains with modified Afg3l2? The knock-
in mouse has a milder phenotype than that of the haploinsufficient strains: (i) in Afg3l2Emv66/+ mice, gait 
alterations develop at 4 months (Maltecca et al., 2009); (ii) in Afg3l2PC-KO mice, gait unsteadiness develops at 
6-8 weeks (Almajan et al., 2012), and (iii)  in Spg7-/-Afg3l2Emv66/+ mice, altered coordination develops at 6 
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weeks (Martinelli et al., 2009). Thus, in terms of late-onset mild ataxia, the Afg3l2M665R/+ mouse appears to 
more faithfully represent the SCA28 phenotype.  
In SCA28, there is MRI evidence of cerebellar atrophy with Purkinje cell loss in almost all patients 
analysed. Despite the detailed investigation, we found no evidence of cerebellar pathology in the knock-in 
mice. On the other hand: 1) this is consistent with the mildness of the motor deficits observed; 2) severe ataxia 
may occur in the absence of signs of neurodegeneration (White et al., 2016); 3) although expression of Afg3l1 
is low in cerebellum, we cannot exclude that even small amounts may attenuate the knock-in phenotype. This 
could be a future area of investigation. Purkinje cell numbers were normal, without the dark cell degeneration 
described in the Afg3l2Emv66/+ mice (Maltecca et al., 2009). We postulate that the most likely cause of motor 
incoordination in Afg3l2M665R/+ mice must be a qualitative rather that quantitative alteration of Purkinje cells. 
An indication of altered function was their tendency towards increased action potential firing. This tendency 
could be linked to impaired buffering of the ionic currents underlying the firing activity, and could represent 
an initial sign of Purkinje cell dysfunction, leading to their incapacity to depolarize correctly. 
Purkinje cell dysfunction points to the crucial role of AFG3L2 in maintaining functional organelles 
and regulating mitochondrial dynamics (Koppen and Langer, 2007; Koppen et al., 2007). With their complex 
dendritic arborizations and synapses, Purkinje cells require a healthy and extensive mitochondrial network for 
ATP synthesis, axonal transport, and to buffer calcium influx. This network is maintained by a delicate balance 
between the opposing forces of mitochondrial fusion and fission. A particular feature of Purkinje cell 
mitochondria is that they have a longer lifespan than those of other tissues, making them more vulnerable to 
the cumulative effects of oxidative, proteotoxic, DNA and other forms of damage (Chen et al., 2007).  
How does Afg3l2 - p.Met665Arg affect the function of the m-AAA protease and lead to mitochondrial 
dysfunction? We addressed this question using the mouse embryonic fibroblast model, which revealed various 
mitochondrial alterations. Firstly, there was evident increased mitochondrial fragmentation in homozygous 
Afg3l2M665R/M665R MEFs, whereas Afg3l2M665R/+ MEFs displayed an intermediate/tubular phenotype. 
Fragmentation of the mitochondrial network is known to be caused by an imbalance in proteolytic cleavage of 
Opa1, which together with the back-up protease Oma1, is one of the determinants of mitochondrial survival 
(Rugarli and Langer, 2012). Our findings of increased fragmentation were corroborated by biochemical 
evidence of overproduction of the short isoform of Opa1 (in particular S1 and S3 isoforms) in Afg3l2M665R/M665R 
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and Afg3l2M665R/+ MEFs. Extensive mitochondrial fragmentation was also detected in Afg3l2Emv66/Emv66 MEFs 
(Maltecca et al., 2009). Proceeding from the MEF cellular model to the whole organism, we also observed 
impaired Opa1 processing in cerebellar lysates of 18-month old Afg3l2M665R/+ mice, suggesting this could be 
one of the early events in SCA28 pathogenesis, although patient mitochondria have yet to be analysed. 
Increased processing of Opa1 could also play an important role in the perinatal lethality of the homozygous 
knock-in mice. Opa1 is central for cardiac function, especially during cardiomyocyte differentiation and heart 
development (Wai et al., 2015). Like Opa1, Afg3l2 is also highly expressed in the developing heart 
(http://www.genecards.org/cgi-bin/carddisp.pl?gene=AFG3L2&keywords=afg3l2), possibly linking the two 
proteases in the perinatal lethality of the knock-in mouse, which will be a future avenue of research.  
Altered Opa1 cleavage has also been associated with enhanced apoptosis (Jiang et al., 2014; Rugarli 
and Langer, 2012), altered morphology of mitochondrial cristae, and decreased cell respiration and ATP 
production (Anand et al., 2014). This is consistent with the impaired bioenergetics observed in Afg3l2M665R/M665R 
MEF mitochondria that revealed significantly reduced respiration and ATP synthesis. Altered Opa1 processing 
in Afg3l2M665R/M665R MEFs may be linked to the decrease in mitochondrial membrane potential compared to 
WT MEFs, which has been shown to induce activation of the ATP-independent zinc metalloprotease Oma1 
which, in turn, promotes Opa1 proteolytic cleavage (Zhang et al., 2014). Indeed, increased pre-pro-Oma1 (60 
kDa form) was detected in Afg3l2M665R/M665R MEFs, supporting its activated state (Head et al., 2009; Korwitz 
et al., 2016).  
Based on the results presented here, we hypothesize that Afg3l2 p.Met665Arg reduces the processing 
capability/rate of m-AAA, resulting in failure to turnover damaged or misfolded mitochondrial proteins, 
together with the accumulation of de novo synthesized proteins in organello. The burden of newly synthesized 
mitochondrial proteins may provoke inner membrane depolarization which, in association with protetoxic 
stress, activates the Oma1 protease. Consequently, Opa1 processing is impaired, fragmentation is enhanced 
and the mitochondrial network is disrupted, causing a functional alteration of the cell, and ultimately impairing 
neuronal functions (Fig. 7). Therefore, we decided to block mitochondrial de novo protein synthesis using the 
antibiotic chloramphenicol, a broad spectrum antibiotic that inhibits translation in both mitochondria and 
prokaryotes (Bulkley et al., 2010; Richter et al., 2015). By blocking mitochondrial protein synthesis, we were 
able to restore the correct balance between Opa1 isoforms and re-establish the mitochondrial network in 
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Afg3l2M665R/M665R MEFs. This result demonstrates that the p.Met665Arg mutation in Afg3l2 affects the 
chaperone and proteolytic functions of the m-AAA complex, reducing protein quality surveillance in 
mitochondria. In agreement with this, bioinformatics analysis of AFG3L2 p.Met666Arg missense change 
showed that the electrostatic potential difference of the homohexamer complex central pore is altered with 
respect to wild-type AFG3L2, pointing to a reduction in the capacity of m-AAA to deliver substrates to the 
proteolytic chamber, or to a weaker interaction among monomers (Cagnoli et al., 2010). Chloramphenicol may 
also be affecting crosstalk between mitochondria and nucleus, as stalled translation might activate a retrograde 
signal to the nucleus, resulting in a compensatory pathway that inhibits Opa1 cleavage. 
Experimental data involving the m-AAA protease must take into account that its roles are only partially 
understood. In mice, Afg3l1 (a pseudogene in humans), a third paralogue of Afg3l2 and Spg7, can modulate 
m-AAA function. Thus, at least five different types of m-AAA complexes are formed (Afg3l2  x 6; Afg3l1 x 
6; Afg3l2 + Spg7; Afg3l2 + Afg3l1 and Afg3l1 + Spg7) (Koppen et al., 2007) and different hexamers may 
have distinct substrate or tissue specificities. For example, we know that Afg3l1 is the least expressed of the 
subunits in all tissues analysed, especially in cerebellum and brain (Sacco et al., 2010). In the presence of a 
mutated Afg3l2 with impaired protease activity, paraplegin and Afg3l1 subunits could be sequestered in non-
functional hetero-hexameric complexes, reducing the amount of functional m-AAA complexes. In contrast, 
Afg3l2 deficiency would lead to the complete absence of protein, allowing Afg3l1 homo-hexamers and 
Afg3l1/Spg7 hetero-hexamers to form functional m-AAA complexes. Such a compensatory effect that has 
been demonstrated in Afg3l2PC-KO mouse oligodendrocytes (Almajan et al., 2012).  
In Afg3l2M665R/+ mice, Afg3l2 synthesis is not impaired and a physiological number of m-AAA 
complexes should be formed, with wild-type and mutated subunits participating equally. We propose that a 
certain quantity of mutant Afg3l2 subunits can be tolerated, allowing normal m-AAA function to be maintained 
(up to a point). Thus we speculate that the heterozygous knock-in mice form a greater number of functional 
(or partially functional) m-AAA hexamers than in the heterozygous knockout mice, explaining the less severe 
phenotype. Indeed, all the previous mouse models strongly support a gene dosage effect of the three subunits 
(Afg3l2, Afg3l1 and Spg7) in determining the functional outcome of m-AAA hexamers (Ferreirinha et al., 
2004; Maltecca et al., 2008; Maltecca et al., 2009; Martinelli et al., 2009; Wang et al., 2016). However, given 
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that we ignore the m-AAA subunit stoichiometry and the reciprocal disposition of the subunits 
(alternate/continuous) in the complex, it remains a speculative hypothesis that warrants further experiment.  
The role of Afg3l2 in Spg7 processing may also shed light on the effect of p.Met665Arg. Spg7 must 
be processed at two cleavage sites to activate its protease activity, the latter being dependent on Afg3l2/Afg3l1 
(Koppen et al., 2009). By electron microscopy, sciatic nerves of Afg3l2M665R/+ mice show swollen mitochondria 
with disrupted cristae, corroborating the idea that the Afg3l2-paraplegin complex, highly represented in the 
peripheral nervous system, is also affected in our knock-in model (Koppen et al., 2007; Sacco et al., 2010).  
In conclusion, we have investigated the molecular mechanisms leading to SCA28 with a newly 
developed knock-in mouse model which we believe better mimicks the human disease than previous models. 
We propose that mitochondrial proteostasis, leading to slow and toxic accumulation, is the pathogenic 
triggering event. Our findings open a novel therapeutic route, based on the modulation of mitochondrial 
translation, to be investigated in future studies. 
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FIGURE LEGENDS 
Figure 1. Production and molecular characterization of Afg3l2 knock-in mice. (A). Schematic diagram of wild-
type Afg3l2 (WT) and the Afg3l2M665R (KI) allele after gene targeting by recombineering. The Southern blot 
probe (orange rectangle) discriminates between WT and KI alleles after NcoI/SmiI digestion (17.1 kb and 13.4 
kb, respectively). (B). Representative Southern blot of DNA extracted from targeted 129 ES cells: DNAs #56, 
#117 and #85 show bands indicating the presence of both WT and KI alleles. (C). Real-time PCR quantification 
of neor cassette copy number in KI-positive DNAs. DNA #56 and #117 are single copy for neor, indicating 
one vector integration event; DNA #85 shows multiple copies of neor and was discarded. The histogram 
represents mean ± SD of three independent experiments. (D). RT-PCR and Sanger sequencing of cerebellar 
Afg3l2 cDNA from WT and heterozygous (Hz) mutant mice. (E). Detection of Afg3l2 proteins by western blot 
in cerebellar extracts from WT and Hz mice. (F). Histogram shows protein expression ratio between Afg3l2 
and and β-actin, and represents mean ± SD of three independent experiments.  
 
Figure 2. Motor test battery performance, cerebellar morphology and Purkinje cell electrophysiology of 18-
month-old Afg3l2M665R/+ and wild-type mice. (A). Graph shows the number of slips made on the beam test by 
wild-type (WT, Afg3l2+/+) and heterozygous (Hz, Afg3l2M665R/+) mice on two different test days (* is p < 0.05, 
Student’s t-test). (B). Examples of footprint analysis to evaluate gait in WT and Hz mice, showing stride length, 
stance and front paw/hind paw distance. Differences were not statistically significant (Student’s t-test). (C). 
Results of accelerated rotarod tests carried out on five consecutive test days, and on day 10. Time to fall is 
shown; WT and Hz mice showed similar results (repeated measures two-way ANOVA). Values are mean ± 
S.E.M. (D, E). Nissl-stained sagittal sections of cerebella from 18-month-old wild type (WT) and heterozygous 
Afg3l2M665R/+ mice. Molecular layer (ml), granular layer (gl) and Purkinje cell layer (pcl) are indicated. (F, G). 
Calbindin-stained sagittal cerebellar sections from 18-month-old wild type and heterozygous mice. Scale bars 
100 µm. (H-J). Histograms show the average thickness of the molecular (H) and granular layers (I), and 
Purkinje cell density (J) of the cerebellar cortex in WT and Hz mouse, showing no significant differences 
between genotypes (p > 0.05, Student’s t-test). Results are reported as mean ± SEM. Scale bars 100 µm. (K). 
Representative histogram showing the distribution of the interspike intervals (ISIs) in Purkinje cells from WT 
and Hz mice. (L-N). Histograms represent the mean ISI (L), the ISI coefficient of variation (M) and the ISI 
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median (N) of WT (n = 24) and Hz (n = 29) Purkinje cells. No significant differences were observed between 
genotypes (p > 0.05, unpaired Student’s t-test). The experiment has been repeated on a second set of Purkinje 
cells, which confirmed the absence of a significant difference 
 
Figure 3. Ultrastructural analyses of cerebellum, spinal cord and sciatic nerve in wild-type and Afg3l2M665R/+ 
mice. (A, B). Photomicrographs show ultrastructure of Purkinje cells and the inner granular layer from 
cerebella isolated from 18-month-old wild-type and heterozygous mutant mice. Scale bar 2 µm; (C, D). 
Purkinje cell mitochondria. Scale bar 500 nm; (E, F). Cells of the granular layer. Scale bar 2 µm. (G, H). 
Myelinated nerve fibers in the spinal cord white matter; Scale bar 20 µm; (I-J) High magnification of axonal 
mitochondria. Scale bar 500 nm. (K, L). Resin-embedded, 2.5 µm semithin sections of sciatic nerves derived 
from wild-type and Afg3l2M665R/+ mice. Toluidine blue stain. Scale bar 20 µm. (M-P). Histograms of sciatic 
nerve stereological analysis showing comparative analyses of total numbers of myelinated fibers (M), axon 
diameter (N), fiber diameter (O) and myelin thickness (P). No significant differences between genotypes were 
observed (Student’s’ t-test). (Q, R). Representative photomicrographs of sciatic nerve obtained by transmission 
electron microscopy: swollen mitochondria without cristae are detectable in Afg3l2M665R/+ mice (red asterisk). 
Scale bar 200 nm (Q) and 500 nm (R).  
 
Figure 4. Comparative analysis of mitochondrial bioenergetics in mouse embryonic fibroblasts (MEFs). (A). 
Oxygen consumption rate (OCR) was measured by Seahorse assay in wild-type (WT), heterozygous (Hz, 
Afg3l2M665R/+) and homozygous (Ho, Afg3l2M665R/M665R) mutant MEFs. Grey dotted lines show the time point 
and order in which the indicated compounds (Oligomycin → FCCP → Rotenone → Antimycin) were added. 
(B). Results of TMRM (Tetramethylrhodamine, methyl ester) assay to measure mitochondrial membrane 
potential in WT, Hz and Ho MEFs (* is p < 0.05, Student’s t-test). (C). ATP synthesis assay in digitonin-
permeabilized cells comparing CI-driven and CII-driven ATP synthesis in WT, Hz and Ho MEFs (* is p < 
0.05, Student’s t-test). (D). Analysis of citrate synthase activity in MEFs. (E). Spectrophotometric analysis in 
isolated mitochondrial fractions showing normal complex I, II and IV activity. Complex III is significantly 
reduced (30%) in homozygous (Ho) mutants with respect to WT and Hz (* is p < 0.05, Student’s t-test). 
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Figure 5. Mitochondrial dynamics in MEFs  
(A). Representative images obtained by live confocal microscopy showing mitochondrial morphology in wild-
type, Afg3l2M665R/+ (Hz) and Afg3l2M665R/M665R (Ho) MEFs after staining with mitoRED fluorescent probe. (B). 
Morphometric analysis of mitochondrial morphology: mitochondria from 50 MEF cells per genotype were 
measured along the length of the major mitochondrial axis. Histograms represent mean ± SD of four 
independent experiments (a.u., arbitrary units). WT vs. either Hz or Ho (*** is p < 0.0001, Student’s t-test, 
two-tailed). (C). Immunoblot of MEF total lysates stained for Opa1; Hsp70, loading control. (D). Immunoblot 
analysis of Opa1 processing in homogenates of neuronal tissues from WT and heterozygous Afg3l2M665/+ mice. 
Histograms below gels show the ratio between short and long Opa1 isoforms.  
 
Figure 6. Rescue of mitochondrial dynamics by chloramphenicol treatment  
(A). Representative images obtained by live confocal microscopy showing mitochondrial morphology in 
MEFs stained with mitoRED probe. Cells were untreated or treated with 200 µg/ml chloramphenicol. (B). 
Immunoblot analysis of total lysates obtained from MEFs untreated or treated with CAM; Hsp70 was used as 
loading control. (C). Immunoblot analysis of MEF total lysates treated with chloramphenicol, 3h and 24h after 
CAM wash-out. Vinculin was used as loading control. 
 
Figure 7. Pathogenic mechanisms triggering SCA28  
Mitochondria have an elaborate proteolytic system, present within different subcompartments of the organelle, 
which coordinates the maturation and processing of newly synthesized proteins and the elimination of non-
assembled polypeptides to avoid potential deleterious effects on organelle function. In physiological conditions 
(left), the m-AAA exerts crucial functions in mt protein quality control: (i) it participates in unfolded mt-protein 
degradation; (ii) it is involved in processing and maturation of mt-proteins; (iii) it has chaperoning activity, 
helping mt-proteins insert into the inner mitochondrial membrane. The processing capability/rate of the m-
AAA is reduced or blocked, proportionally to the number of Afg3l2 p.Met665Arg integrated in the complex 
(right), resulting in (1) the accumulation of non-processed and misfolded proteins in the organelles that lack 
processing or degradation by the m-AAA protease. This burden of newly synthesized mt-proteins derived from 
impairment of the mitochondrial proteolytic system, activates OMA1 protease (3), directly or through an inner 
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membrane depolarization (2). Consequently, Opa1 processing is enhanced (4), leading to fragmentation of the 
mitochondrial network (5). Chloramphenicol, acting by inhibiting de novo translation in mt-ribosomes, 
prevents the accumulation of newly synthesized proteins and reduces stress signals in the inner membrane, 
thus rescuing the cascade of events leading to Opa1 enhanced processing and mt-fragmentation. 
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SUPPORTING INFORMATION LEGENDS 
 
Figure S1. Comparative analysis of whole embryos and selected tissue histology of E16.5 embryos 
(A). Photograph showing intact E16.5 embryos isolated from homozygous mutant, wild-type and heterozygous 
mutant lineages. (B, C). Histological section of heart derived from E16.5 WT (left panel) and homozygous 
mutant (right panel) mice. (D, E). Cerebellar sections from WT (left panel) and homozygous mutant mice 
(right panel). Cerebellum is outlined in red dotted line. Hematoxylin/eosin stain.  
 
Figure S2. Seahorse assay for mitochondrial function and mitochondrial protein analysis in MEFs  
(A). Histograms represent results of seahorse assays in wild-type (WT), heterozygous Afg3l2M665R/+ (Hz) and 
homozygous Afg3l2M665R/M665R embryonic fibroblasts. Double asterisks (**) shows statistically significant 
reduction in basal and maximal oxygen consumption rate (OCR), spare OCR capacity and ATP-linked OCR 
in both Hz and Ho mutants with respect to WT. Single asterisk (*) shows proton leakage reduction was 
statistically significant only in Hz compared to WT (p < 0.05, Student’s t-test, two tailed). (B). Analysis of 
mitochondrial protein synthesis by pulsed 35S metabolic labelling in WT and Hz MEFs (left panel), and WT 
and Ho MEFs (right panel). Labelled proteins were separated by 12-20% SDS-PAGE and visualized by 
autoradiography. To control for protein loading, part of the gels was stained with Coomassie blue. (C). 
Immunoblot analysis of mitochondrial lysates from MEFs showing the steady-state levels of respiratory 
complex subunits. β-actin, loading control. (D). In-gel activity (IGA) of complex I and blue native (BN) page 
immunoblot analysis of fully assembled respiratory complexes II, III and IV. A mild reduction in CIII assembly 
was observed in Ho compared to WT (asterisk*). Mitochondrial proteins Sdha and Vdac were use as loading 
controls. (E). Immunoblot analysis showing the steady-state levels of fission/fusion regulatory proteins 
Mitofusin 1 and 2 (Mfn1, 2), and Dynamin-related protein 1 (Drp1) in MEF total lysates.   
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